VIM and neoplasm: Other indications for mechanisms of region-specific tumour survival were revealed by IMC, as well as cell-cycle-specific drug-induced responses, including indications of a significant loss of mesenchymal characteristics indicated by the localisation of Vimentin in all regions other than the outer edge following the introduction of the chemotherapeutic agent.